FDA approves Sanofi and Regeneron’s new eczema drug
The US Food and Drug Administration (FDA) approved Sanofi and Regeneron's Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis).
List view / Grid view
News
NICE does not recommend Shire’s pancreatic cancer drug
3 April 2017 | By Niamh Marriott, Junior Editor
The National Institute or Health and Care Excellence (NICE) has published final guidance that does not recommend pegylated liposomal irinotecan (Onivyde, Shire).
Cherwell makes an impact – with new continuous monitoring microbial air samplers
31 March 2017 | By Cherwell Laboratories
ImpactAir® high performance air sampler range joins Cherwell’s portfolio of cleanroom microbiology products...
First female CEO of GSK to be paid 25% less than her male predecessor
31 March 2017 | By Niamh Marriott, Junior Editor
Emma Walmsley will succeed Andrew Witty as GSK CEO, when he retires on 31 March 2017, making her the first female CEO of a major global pharmaceuticals company.
AstraZeneca’s potential drug for neuromyelitis optica spectrum disorder receives EU orphan designation
30 March 2017 | By Niamh Marriott, Junior Editor
AstraZeneca and its global biologics research and development arm, MedImmune, announced that the European Medicines Agency (EMA) has granted orphan designation to inebilizumab (formerly MEDI-551) for the treatment of neuromyelitis optica spectrum disorder (NMOSD).
Precision NanoSystems NanoAssemblr™ chosen for Horizon 2020 project to develop novel RNA therapeutics
29 March 2017 | By Precision NanoSystems
Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project...
Rainin’s pipette service puts the customer first
29 March 2017 | By Mettler Toledo
Careful maintenance of precision pipettes is essential in the highly regulated pharmaceutical and clinical diagnostics industries...
Merrimack initiates Phase 1 study of MM-310 in solid tumours
29 March 2017 | By Niamh Marriott, Junior Editor
Merrimack Pharmaceuticals have enrolled its first patient in a Phase 1 study of MM-310 in solid tumours.
Enhance your workflow efficiency with rapid tube identification
29 March 2017 | By Tecan
Tecan is helping to reduce waiting times for bulk sample identification with an innovative high speed barcode scanner for its Fluent® Laboratory Automation Solution...
Discover the Rainin SmartStand™, the world’s first intelligent pipette stand
29 March 2017 | By Mettler Toledo Rainin, LLC
METTLER TOLEDO’s recently launched Rainin SmartStand™ is set to transform pipette management...
NICE does not recommend Janssen’s multiple myeloma drug
29 March 2017 | By Niamh Marriott, Junior Editor
NICE) has published new draft guidance not recommending daratumumab monotherapy (Darzalex, Janssen) to treat some people with multiple myeloma...
Single cell technology company Dolomite Bio celebrates a successful first year
28 March 2017 | By Dolomite Bio
Dolomite Bio, a brand of Blacktrace Holdings Limited, celebrated the first anniversary of its launch on March 1st, marking the end of a fruitful year in business...
Nektar’s opioid analgesic meets endpoints in Phase 3 Study of chronic pain
28 March 2017 | By Niamh Marriott, Junior Editor
Nektar Therapeutics announced positive results from the SUMMIT-07 Phase 3 efficacy study of NKTR-181, an opioid analgesic...
Butterworth Laboratories Ltd is delighted to announce expansion
28 March 2017 | By Butterworth Laboratories Ltd
Leading UK contract analytical chemistry provider, Butterworth Laboratories Ltd, is delighted to announce it has secured an additional facility in Hampton, Middlesex as part of a project to expand UK laboratory operations by 15% in 2017...
Covectra launches anti-counterfeit barcode labelling system
27 March 2017 | By Steve Bremer, Managing Editor
Covectra has launched an anti-counterfeit, tamper-evident, barcode labelling system
